Hendrik Peter Scholl, Chief Officer of Belite Bio BLTE, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $2.9M. The latest trade was on 06/18.

HS

HS

Hendrik Peter Scholl

Chief Medical Officer

Company

Belite Bio BLTE

First filing

26/04/23

Trades

14 trades

Buys / sales

0 / 13

12-month net buying

−$2.9M

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Belite BioBLTE	Open-market sale	06/18	06/22	10,000 sh5 trades	$145.24avg.	$1,452,399.63	−40.0%
Belite BioBLTE	Open-market sale	06/16	06/17	10,000 sh8 trades	$140.57avg.	$1,405,730.11	−28.6%